BOKU - Universität für Bodenkultur Wien - Forschungsinformationssystem

Logo BOKU-Forschungsportal

Kunert Renate

Unter PUBLIKATIONEN werden die wissenschaftlichen Publikationen der BOKU Forscher und BOKU Forscherinnen gelistet, insbesondere Veröffentlichungen in SCI- / SSCI-gelisteten und in anderen referierten Fachzeitschriften. Weiters Beiträge in Sammelwerken, Proceedings sowie Monographien.

Wissenschaftliche Veröffentlichungen mit besonderem Fokus auf Wissenstransfer ("gesellschaftlicher Impakt") an Anwender, Praxisakteure sowie die interessierte Öffentlichkeit finden Sie nun unter dem NEUEN Menüpunkt:

>> Wissenstransfer


** = Publikationen gelistet in SCI/SSCI (veröffentlicht im Web of Science)
* = Publikationen in sonstigen peer-reviewten Journalen (ggf. noch nicht im WoS veröffentlicht)
Filter: Originalarbeit, Übersichtsarbeit, Konferenzband Originalarbeit

= Open Access - Publikationen

 

2020

Originalbeitrag in Fachzeitschrift

** Hennicke, J; Schwaigerlehner, L; Grunwald-Gruber, C; Bally, I; Ling, WL; Thielens, N; Reiser, JB; Kunert, R Transient pentameric IgM fulfill biological function-Effect of expression host and transfection on IgM properties.

PLOS ONE. 2020; 15(3), e0229992 WoS PubMed FullText FullText_BOKU

** Lobner, E; Wachernig, A; Gudipati, V; Mayrhofer, P; Salzer, B; Lehner, M; Huppa, JB; Kunert, R Getting CD19 Into Shape: Expression of Natively Folded "Difficult-to- Express" CD19 for Staining and Stimulation of CAR-T Cells.

FRONT BIOENG BIOTECH. 2020; 8, 49 WoS PubMed FullText FullText_BOKU

** Mayrhofer, P; Reinhart, D; Castan, A; Kunert, R; Rapid development of clone-specific, high-performing perfusion media from established feed supplements..

Biotechnol Prog. 2020; 36(2):e2933 WoS PubMed FullText FullText_BOKU

Originalbeitrag in Sammelwerk

Hennicke, J; Kunert, R (2020): Analysis of Product Quality of Complex Polymeric IgM Produced by CHO Cells.

In: Pörtner R. (eds), Animal Cell Biotechnology. Methods in Molecular Biology 2095, 295-302 ; Humana, New York; ISBN 978-1-0716-0191-4 FullText

Mayrhofer,P; Kunert,R (2020): Screening of Media Supplements for High-Performance Perfusion Cultures by Design of Experiment.

In: Pörtner R. (eds), Animal Cell Biotechnology. Methods in Molecular Biology 2095, 27-39; Humana, New York; ISBN 978-1-0716-0191-4 FullText

2019

Originalbeitrag in Fachzeitschrift

** Hennicke, J; Reinhart, D; Altmann, F; Kunert, R Impact of temperature and pH on recombinant human IgM quality attributes and productivity.

NEW BIOTECHNOL. 2019; 50: 20-26. WoS PubMed FullText FullText_BOKU

** Reinhart, D; Damjanovic, L; Kaisermayer, C; Sommeregger, W; Gili, A; Gasselhuber, B; Castan, A; Mayrhofer, P; Grünwald-Gruber, C; Kunert, R; Bioprocessing of Recombinant CHO-K1, CHO-DG44, and CHO-S: CHO Expression Hosts Favor Either mAb Production or Biomass Synthesis..

Biotechnol J. 2019; 14(3):e1700686 WoS PubMed FullText FullText_BOKU

** Schwaigerlehner, L; Mayrhofer, P; Diem, M; Steinfellner, W; Fenech, E; Oostenbrink, C; Kunert, R; Germinality does not necessarily define mAb expression and thermal stability..

Appl Microbiol Biotechnol. 2019; 103(18):7505-7518 WoS PubMed FullText FullText_BOKU

** Trattnig, N; Mayrhofer, P; Kunert, R; Mach, L; Pantophlet, R; Kosma, P Comparative Antigenicity of Thiourea and Adipic Amide Linked Neoglycoconjugates Containing Modified Oligomannose Epitopes for the Carbohydrate-Specific anti-HIV Antibody 2G12.

BIOCONJUGATE CHEM. 2019; 30(1): 70-82. WoS PubMed FullText FullText_BOKU

* Mayrhofer, P; Kunert, R; (2019): Nomenclature of humanized mAbs: Early concepts, current challenges and future perspectives..

Hum Antibodies. 2019; 27(1):37-51 PubMed PUBMED Central FullText FullText_BOKU

PUBLIZIERTER Beitrag für wissenschaftliche Veranstaltung

** Reiser, JB; Hennicke, J; Bally, I; Chouquet, A; Ling, WL; Reinhart, D; Altmann, F; Kunert, R; Thielens, N EVALUATION OF C1q BINDING AND COMPLEMENT ACTIVATION OF NEW RECOMBINANT HUMAN IGMS AS QUALITY PRODUCTION ATTRIBUTES.
[17th European Meeting on Complement in Human Disease (EMCHD), Madrid, SPAIN, 2019]

MOL IMMUNOL. 2019; 114: 426-426. WoS

J.-B. Reiser, J. Hennicke, I. Bally, A. Chouquet, W.-L. Ling, F. Altmann, R. Kunrt, N. Thielens (2019): Evaluation of C1p binding and complement activation of new recombinant human IgMs as quality attributes.. [Poster]
[17th European Meeting on Complement in Human Disease, Madrid, September 14th to 17th, 2019]

2018

Originalbeitrag in Fachzeitschrift

** Albrecht, S; Kaisermayer, C; Reinhart, D; Ambrose, M; Kunert, R; Lindeberg, A; Bones, J Multiple reaction monitoring targeted LC-MS analysis of potential cell death marker proteins for increased bioprocess control.

ANAL BIOANAL CHEM. 2018; 410(13): 3197-3207. WoS PubMed FullText FullText_BOKU

** Reinhart, D; Damjanovic, L; Castan, A; Ernst, W; Kunert, R Differential gene expression of a feed-spiked super-producing CHO cell line.

J BIOTECHNOL. 2018; 285: 23-37. WoS PubMed FullText FullText_BOKU

** Schwaigerlehner, L; Pechlaner, M; Mayrhofer, P; Oostenbrink, C; Kunert, R; Lessons learned from merging wet lab experiments with molecular simulation to improve mAb humanization..

Protein Eng Des Sel. 2018; 31(7-8):257-265 WoS PubMed FullText FullText_BOKU

PUBLIZIERTER Beitrag für wissenschaftliche Veranstaltung

** Hennicke, J; Kunert, R Quality matters - Is IgM production influenced by external process conditions?.

NEW BIOTECHNOL. 2018; 44: S144-S144. WoS FullText FullText_BOKU

** Mundsperger, P; Gili, A; Sterovsky, T; Casanova, E; Kunert, R Understanding the heterologous expression of HIV-1 Env glycoproteins in CHO Cells.

NEW BIOTECHNOL. 2018; 44: S144-S144. WoS FullText FullText_BOKU

** Schwaigerlehner, L; Mayrhofer, P; Kunert, R Making the strange more familiar: Influence of germinality content on mAb expression potentials and thermal stability properties.

NEW BIOTECHNOL. 2018; 44: S66-S66. WoS FullText FullText_BOKU

2017

Originalbeitrag in Fachzeitschrift

** Battin, C; Hennig, A; Mayrhofer, P; Kunert, R; Zlabinger, GJ; Steinberger, P; Paster, W A human monocytic NF-kappa B fluorescent reporter cell line for detection of microbial contaminants in biological samples.

PLOS ONE. 2017; 12(5): WoS PubMed PUBMED Central FullText FullText_BOKU

** Hennicke, J; Lastin, AM; Reinhart, D; Grünwald-Gruber, C; Altmann, F; Kunert, R; Glycan profile of CHO derived IgM purified by highly efficient single step affinity chromatography..

Anal Biochem. 2017; 539:162-166 WoS PubMed FullText FullText_BOKU

* Mayrhofer, P; Kunert, R; (2017): Cloning of Single-Chain Antibody Variants by Overlap-Extension PCR for Evaluation of Antibody Expression in Transient Gene Expression..

Methods Mol Biol. 2017; 1603:57-69 PubMed FullText FullText_BOKU

PUBLIZIERTER Beitrag für wissenschaftliche Veranstaltung

Hennicke, J; Reinhart, D; Kunert R (2017): Analyses of product quality of complex polymeric IgM produced by CHO cells. [Poster]
[25th ESACT Meeting, Lausanne, SWITZERLAND, 14.05.2017 - 17.05.2017]

, BMC Proceedings, 12, 26-27

Schwaigerlehner, L; Mayrhofer, P; Pechlaner, M; Oostenbrink, C; Kunert, R (2017): Rational antibody humanization assisted by molecular dynamics simulations. [Poster]
[25th ESACT Meeting, Lausanne, SWITZERLAND, 14.05.2017 - 17.05.2017]

, BMC Proceedings, 12, 61-61

Trattnig, N; Pantophlet, R; Mayrhofer, P; Kunert, R, Kosma, P. (2017): Synthesis and vaccine potential of novel oligomannosides against HIV-1. [Poster]
[VII EFMC International Symposium on Advances in Synthetic and Medicinal Chemistry, Vienna, Aug 27-31, 2017]

In: The European Federation of Medicinal Chemistry, Book of Abstracts, P312

Trattnig, N; Pantophlet, R; Mayrhofer, P; Kunert, R; Kosma, P. (2017): Synthesis and vaccine potential of novel oligomannosides against HIV-1. [Poster]
[19th European Carbohydrate Symposium, Barcelona, Spain, 02.07.2017 - 06.07.2017]

In: Planas, A. (Ed.), Book of Abstracts, P 180

Trattnig, N; Pantophlet, R; Mayrhofer, P; Kunert, R; Kosma, P. (2017): Synthesis and vaccine potential of novel oligomannosides against HIV-1.
[14th Bratislava symposium on saccharides, Smolenice, June 25-30]

In: Katrlík, J; Baráth, M. (Eds.), Proceedings of the 14th Bratislava symposium on saccharides, OP10; ISBN: 978-80-971156-3-0

2016

Originalbeitrag in Fachzeitschrift

** Kaisermayer, C; Reinhart, D; Gili, A; Chang, M; Aberg, PM; Castan, A; Kunert, R Biphasic cultivation strategy to avoid Epo-Fc aggregation and optimize protein expression.

J BIOTECHNOL. 2016; 227: 3-9. WoS PubMed FullText FullText_BOKU

** Kunert, R; Reinhart, D Advances in recombinant antibody manufacturing.

APPL MICROBIOL BIOT. 2016; 100(8): 3451-3461. WoS PubMed PUBMED Central FullText FullText_BOKU

** Margreitter, C; Mayrhofer, P; Kunert, R; Oostenbrink, C Antibody humanization by molecular dynamics simulations-in-silico guided selection of critical backmutations.

J MOL RECOGNIT. 2016; 29(6): 266-275. WoS PubMed FullText FullText_BOKU

** Sommeregger, W; Mayrhofer, P; Steinfellner, W; Reinhart, D; Henry, M; Clynes, M; Meleady, P; Kunert, R; Proteomic differences in recombinant CHO cells producing two similar antibody fragments..

Biotechnol Bioeng. 2016; 113(9):190-112 WoS PubMed PUBMED Central FullText FullText_BOKU

PUBLIZIERTER Beitrag für wissenschaftliche Veranstaltung

** Fazekas, J; Singer, J; Matz, M; Mader, A; Spillner, E; Kunert, R; Jensen-Jarolim, E AllergoOncology: generation of a canine anti-EGFR anticancer IgE.
[Meeting of the European-Academy-of-Allergy-and-Clinical-Immunology, Vienna, AUSTRIA, JUN 11-15, 2016]

; ISSN 0105-4538 WoS

Trattnig, N; Pantophlet, R; Mayrhofer, P; Kunert, R; Kosma, P. (2016): Synthesis of bacterial mimetics of HIV-1 gp120 glycans. [Poster]
[28th International Carbohydrate Symposium, New Orleans, 17.07.2016 - 21.07.2016]

In: French, A (ED), Abstracts, http://ics-2016.org/index-03.html

2015

Originalbeitrag in Fachzeitschrift

** Chromikova, V; Mader, A; Hofbauer, S; Göbl, C; Madl, T; Gach, JS; Bauernfried, S; Furtmüller, PG; Forthal, DN; Mach, L; Obinger, C; Kunert, R; Introduction of germline residues improves the stability of anti-HIV mAb 2G12-IgM..

Biochim Biophys Acta. 2015; 1854(10 Pt A):1536-1544 WoS PubMed FullText FullText_BOKU

** Chromikova, V; Mader, A; Steinfellner, W; Kunert, R; Evaluating the bottlenecks of recombinant IgM production in mammalian cells..

Cytotechnology. 2015; 67(2):343-356 WoS PubMed PUBMED Central FullText FullText_BOKU

** Mayerhofer, B; Stöger, A; Pietzka, AT; Fernandez, HL; Prewein, B; Sorschag, S; Kunert, R; Allerberger, F; Ruppitsch, W; Improved protocol for rapid identification of certain spa types using high resolution melting curve analysis..

PLoS One. 2015; 10(3):e0116713 WoS PubMed PUBMED Central FullText FullText_BOKU

** Reinhart, D; Damjanovic, L; Kaisermayer, C; Kunert, R Benchmarking of commercially available CHO cell culture media for antibody production.

APPL MICROBIOL BIOT. 2015; 99(11): 4645-4657. WoS PubMed PUBMED Central FullText FullText_BOKU

** Reinhart, D; Kunert, R; Upstream and downstream processing of recombinant IgA..

Biotechnol Lett. 2015; 37(2):241-251 WoS PubMed FullText FullText_BOKU

** Zboray, K; Sommeregger, W; Bogner, E; Gili, A; Sterovsky, T; Fauland, K; Grabner, B; Stiedl, P; Moll, HP; Bauer, A; Kunert, R; Casanova, E; Heterologous protein production using euchromatin-containing expression vectors in mammalian cells..

Nucleic Acids Res. 2015; 43(16):e102 WoS PubMed FullText FullText_BOKU

Reinhart, D; Damjanovic, L; Sommeregger, W; Gili, A; Schafellner, S; Castan, A; Kaisermayer, C; Kunert, R (2015): Influence of cell culture media and feed supplements on cell metabolism and quality of IgG produced in CHO-K1, CHO-S, and CHO-DG44.

BMC Proceedings, 9, P36-P36; ISSN 1753-6561

PUBLIZIERTER Beitrag für wissenschaftliche Veranstaltung

Mayrhofer, P; Mader, A; Kratzer, B; Reinhart, D; Steinfellner, W; Sommeregger, W; Kunert, R (2015): Identification of bottlenecks in antibody expression using targeted gene integration. [Poster]
[24th ESACT - Cells, Culture, Patients, Products, Barcelona, Spain, 31.05.2015 - 03.06.2015]

, BMC Proceedings, 9, P7-P7

Puxbaum V., Landes N., Maccani A., Kunert R., Gasser B., Mattanovich D. (2015): Follow the protein: the secretory pathway of recombinant proteins in Pichia pastoris tracked via live cell microscopy .
[6th International Conference on Analysis of Microbial Cells at the Single Cell Level, Retz, 19.-22.7. 2015]

In: European Federation of Biotechnology, 6th International Conference on Analysis of Microbial Cells at the Single Cell Level

2014

Originalbeitrag in Fachzeitschrift

** Fliedl, L; Manhart, G; Kast, F; Katinger, H; Kunert, R; Grillari, J; Wieser, M; Grillari-Voglauer, R Novel human renal proximal tubular cell line for the production of complex proteins.

J BIOTECHNOL. 2014; 176: 29-39. WoS PubMed FullText FullText_BOKU

** Huber, G; Banki, Z; Kunert, R; Stoiber, H Novel Bifunctional Single-Chain Variable Antibody Fragments to Enhance Virolysis by Complement: Generation and Proof-of-Concept.

BIOMED RES INT. 2014; WoS PubMed PUBMED Central FullText FullText_BOKU

** Jadhav, V; Hackl, M; Klanert, G; Bort, JAH; Kunert, R; Grillari, J; Borth, N Stable overexpression of miR-17 enhances recombinant protein production of CHO cells.

J BIOTECHNOL. 2014; 175: 38-44. WoS FullText FullText_BOKU

** Maccani, A; Hackl, M; Leitner, C; Steinfellner, W; Graf, AB; Tatto, NE; Karbiener, M; Scheideler, M; Grillari, J; Mattanovich, D; Kunert, R; Borth, N; Grabherr, R; Ernst, W Identification of microRNAs specific for high producer CHO cell lines using steady-state cultivation.

APPL MICROBIOL BIOT. 2014; 98(17): 7535-7548. WoS PubMed PUBMED Central FullText FullText_BOKU

** Maccani, A; Landes, N; Stadlmayr, G; Maresch, D; Leitner, C; Maurer, M; Gasser, B; Ernst, W; Kunert, R; Mattanovich, D Pichia pastoris secretes recombinant proteins less efficiently than Chinese hamster ovary cells but allows higher space-time yields for less complex proteins.

BIOTECHNOL J. 2014; 9(4): 526-537. WoS PubMed PUBMED Central FullText FullText_BOKU

** Mayrhofer, P; Kratzer, B; Sommeregger, W; Steinfellner, W; Reinhart, D; Mader, A; Turan, S; Qiao, J; Bode, J; Kunert, R; Accurate comparison of antibody expression levels by reproducible transgene targeting in engineered recombination-competent CHO cells..

Appl Microbiol Biotechnol. 2014; 98(23):9723-9733 WoS PubMed PUBMED Central FullText FullText_BOKU

** Reinhart, D; Sommeregger, W; Debreczeny, M; Gludovacz, E; Kunert, R In search of expression bottlenecks in recombinant CHO cell lines-a case study..

Appl Microbiol Biotechnol. 2014; 98(13):5959-5965 WoS PubMed FullText FullText_BOKU

** Singer, J; Fazekas, J; Wang, W; Weichselbaumer, M; Matz, M; Mader, A; Steinfellner, W; Meitz, S; Mechtcheriakova, D; Sobanov, Y; Willmann, M; Stockner, T; Spillner, E; Kunert, R; Jensen-Jarolim, E Generation of a Canine Anti-EGFR (ErbB-1) Antibody for Passive Immunotherapy in Dog Cancer Patients.

MOL CANCER THER. 2014; 13(7): 1777-1790. WoS FullText FullText_BOKU

PUBLIZIERTER Beitrag für wissenschaftliche Veranstaltung

** Fazekas, J; Singer, J; Wang, W; Weichselbaumer, M; Matz, M; Mader, A; Steinfellner, W; Meitz, S; Mechtcheriakova, D; Sobanov, Y; Willmann, M; Stockner, T; Spillner, E; Kunert, R; Jensen-Jarolim, E Can225IgG, the first 'caninised' antibody against EGFR is highly effective in mediating tumor cell growth inhibition and phagocytosis in vitro.
[European-Academy-of-Allergy-and-Clinical-Immunology Congress, Copenhagen, DENMARK, JUN 07-11, 2014]

ALLERGY. 2014; 69: 533-533. WoS

** Fazekas, J; Singer, J; Wang, W; Weichselbaumer, M; Matz, M; Mader, A; Steinfellner, W; Meitz, S; Mechtcheriakova, D; Sobanov, Y; Willmann, M; Stockner, T; Spillner, E; Kunert, R; Jensen-Jarolim, E Can225IgG, a monoclonal antibody targeting EGFR for veterinary oncology.

INT J MOL MED. 2014; 34: S128-S128. WoS

** Fliedl, L; Wieser, M; Manhart, G; Gerstl, MP; Kast, F; Khan, A; Kunert, R; Grillari, J; Grillari-Voglauer, R Novel human kidney epithelial cell line in pharmaceutical biotechnology.

NEW BIOTECHNOL. 2014; 31: S72-S72. WoS FullText FullText_BOKU

** Landes, N; Maccani, A; Leitner, C; Maurer, M; Graf, AB; Valli, M; Gruber, C; Modarres, G; Altmann, F; Gasser, B; Ernst, W; Kunert, R; Mattanovich, D Cross-species comparison of recombinant protein secretion in CHO cells and Pichia pastoris.

NEW BIOTECHNOL. 2014; 31: S4-S4. WoS FullText FullText_BOKU

** Mayrhofer, P; Mader, A; Kunert, R RMCE reference sites - A valuable tool for comparing antibody expression capabilities in CHO cells.

NEW BIOTECHNOL. 2014; 31: S186-S187. WoS FullText FullText_BOKU

** Singer, J; Fazekas, J; Wang, W; Weichselbaumer, M; Matz, M; Mader, A; Steinfellner, W; Meitz, S; Mechtcheriakova, D; Sobanov, Y; Stockner, T; Spillner, E; Kunert, R; Willmann, M; Thalhammer, J; Jensen-Jarolim, E IgE-based immunotherapy of cancer-A comparative oncology approach.

INT J MOL MED. 2014; 34: S127-S127. WoS

** Sommeregger, W; Gili, A; Zboray, K; Sterovsky, T; Casanova, E; Kunert, R Establishment of stable, high producing, recombinant CHO cell lines using Rosa26 Bacterial Artificial Chromosomes for transgene delivery.

NEW BIOTECHNOL. 2014; 31: S187-S187. WoS FullText FullText_BOKU

2013

Originalbeitrag in Fachzeitschrift

** Ladenstein, R; Weixler, S; Baykan, B; Bleeke, M; Kunert, R; Katinger, D; Pribill, I; Glander, P; Bauer, S; Pistoia, V; Michon, J; Garaventa, A; Lode, HN Ch14.18 antibody produced in CHO cells in relapsed or refractory Stage 4 neuroblastoma patients A SIOPEN phase 1 study.

MABS-AUSTIN. 2013; 5(5): 801-809. WoS FullText FullText_BOKU

** Mader, A; Prewein, B; Zboray, K; Casanova, E; Kunert, R; Exploration of BAC versus plasmid expression vectors in recombinant CHO cells..

Appl Microbiol Biotechnol. 2013; 97(9):4049-4054 WoS PubMed FullText FullText_BOKU

** Sommeregger, W; Prewein, B; Reinhart, D; Mader, A; Kunert, R; Transgene copy number comparison in recombinant mammalian cell lines: critical reflection of quantitative real-time PCR evaluation..

Cytotechnology. 2013; 65(5):811-818 WoS PubMed PUBMED Central FullText FullText_BOKU

Mader, A; Chromikova, V; Kunert, R (2013): Recombinant IgM expression in mammalian cells: A target protein challenging biotechnological production.

Advances in Bioscience and Biotechnology, 4, 38-43; ISSN 2156-8456 FullText

* Reinhart, D; Kaisermayer, C; Kunert, R (2013): Benchmarking of commercially available CHO cell culture media for antibody production.

BMC Proceedings, 7, P13-P13; ISSN 1753-6561 FullText

* Reinhart, D; Sommeregger, W; Debreczeny, M; Gludovacz, E; Kunert, R (2013): Characterization of recombinant IgA producing CHO cell lines by qPCR.

BMC Proceedings, 7, P114-P114; ISSN 1753-6561 FullText

PUBLIZIERTER Beitrag für wissenschaftliche Veranstaltung

** Fazekas, J; Singer, J; Wang, W; Weichselbaumer, M; Matz, M; Mader, A; Steinfellner, W; Meitz, S; Mechtcheriakova, D; Sobanov, Y; Stockner, T; Spillner, E; Kunert, R; Jensen-Jarolim, E Passive anti-EGFR immunotherapy in canine cancer patients - a comparative medicine study.
[World Allergy and Asthma Congress of the European-Academy-of-Allergy-and-Clinical-Immunology and World-Allergy-Organization, Milan, ITALY, JUN 22-26, 2013]

ALLERGY. 2013; 68: 590-590. WoS

Landes, N; Maccani, A; Leitner, C; Maurer, M; Gasser, B; Ernst, W; Kunert, R; Mattanovich, D. (2013): Cross-species comparison of recombinant protein secretion in CHO cells and Pichia pastoris. [Poster]
[7th Conference on Recombinant Protein Production – RPP7, Laupheim, Germany, March 6-8, 2013]

In: European Federation of Biotechnology, RPP7-Abstract Book

Maccani, A., Tatto, N., Graf, A., Leitner, C., Mattanovich, D., Kunert, R., Ernst, W. (2013): Transcriptome study of high and low producing recombinant Chinese hamster ovary cell lines. [Poster]
[7th Conference on Recombinant Protein Production – RPP7, Laupheim, Germany, March 6-8, 2013]

In: European Federation of Biotechnology, RPP7-Abstract Book

Sommeregger, W; Gili, A; Sterovsky, T; Casanova, E; Kunert, R (2013): Powerful expression in Chinese Hamster Ovary cells using bacterial artificial chromosomes: parameters influencing productivity. [Poster]
[23rd ESACT Meeting - Better Cells for Better Health, Lille, FRANCE, 23.06.2013 - 26.06.2013]

, BMC Proceedings, 7; ISBN: doi:10.1186/1753-656

2012

Originalbeitrag in Fachzeitschrift

** Huarte, N; Araujo, A; Arranz, R; Lorizate, M; Quendler, H; Kunert, R; Valpuesta, JM; Nieva, JL Recognition of Membrane-Bound Fusion-Peptide/MPER Complexes by the HIV-1 Neutralizing 2F5 Antibody: Implications for Anti-2F5 Immunogenicity.

PLOS ONE. 2012; 7(12): WoS FullText FullText_BOKU

** Jadhav, V; Hackl, M; Hernandez Bort, JA; Wieser, M; Harreither, E; Kunert, R; Borth, N; Grillari, J A screening method to assess biological effects of microRNA overexpression in Chinese hamster ovary cells..

Biotechnol Bioeng. 2012; 109(6):1376-1385 WoS PubMed FullText FullText_BOKU

** Mader, A; Kunert, R; Evaluation of the potency of the anti-idiotypic antibody Ab2/3H6 mimicking gp41 as an HIV-1 vaccine in a rabbit prime/boost study..

PLoS One. 2012; 7(6):e39063 WoS PubMed PUBMED Central FullText FullText_BOKU

** Reinhart, D; Weik, R; Kunert, R; Recombinant IgA production: single step affinity purification using camelid ligands and product characterization..

J Immunol Methods. 2012; 378(1-2):95-101 WoS PubMed

** Rodriguez-Carmona, E; Cano-Garrido, O; Dragosits, M; Maurer, M; Mader, A; Kunert, R; Mattanovich, D; Villaverde, A; Vazquez, F Recombinant Fab expression and secretion in Escherichia coli continuous culture at medium cell densities: Influence of temperature.

PROCESS BIOCHEM. 2012; 47(3): 446-452. WoS FullText FullText_BOKU

** Taschwer, M; Hackl, M; Hernández Bort, JA; Leitner, C; Kumar, N; Puc, U; Grass, J; Papst, M; Kunert, R; Altmann, F; Borth, N Growth, productivity and protein glycosylation in a CHO EpoFc producer cell line adapted to glutamine-free growth..

J Biotechnol. 2012; 157(2):295-303 WoS PubMed FullText FullText_BOKU

** Zeinzinger, J; Pietzka, AT; Stoger, A; Kornschober, C; Kunert, R; Allerberger, F; Mach, R; Ruppitsch, W One-Step Triplex High-Resolution Melting Analysis for Rapid Identification and Simultaneous Subtyping of Frequently Isolated Salmonella Serovars.

APPL ENVIRON MICROB. 2012; 78(9): 3352-3360. WoS PubMed PUBMED Central FullText FullText_BOKU

* Kunert, R; Vorauer-Uhl, K; (2012): Strategies for efficient transfection of CHO-cells with plasmid DNA..

Methods Mol Biol. 2012; 801:213-226 PubMed FullText FullText_BOKU

PUBLIZIERTER Beitrag für wissenschaftliche Veranstaltung

Mader, A; Kunert, R (2012): Human recombinant IgMs: a challenging molecule in mammalian cell expression. [Poster]
[15th European Congress on Biotechnology, Istanbul, TURKEY, SEP 23-26, 2012]

, New Biotechnology, 29, 1-242; ISSN 1871-6784

Originalbeitrag in Sammelwerk

Renate Kunert (2012): The Neutralizing Anti-HIV Antibody 2G12.

In: Paul Kosma, Sven Müller-Loennies, Anticarbohydrate Antibodies, 147-160; Springer-Verlag, Wien; ISBN 978-3-7091-0869-7

2011

Monographie

Renate Kunert, Karola Vorauer-Uhl (2011): Protein expression in mammalian cells: "Strategies for efficient transfection of CHO-cells with plasmid DNA".

, 14, Springer, New York; ISBN: 978-1-61779-351-6

Originalbeitrag in Fachzeitschrift

** de Ruiter, A; Mader, A; Kunert, R; Oostenbrink, C Molecular Simulations to Rationalize Humanized Ab2/3H6 Activity.

AUST J CHEM. 2011; 64(7): 900-909. WoS FullText FullText_BOKU

** Dragosits, M; Frascotti, G; Bernard-Granger, L; Vazquez, F; Giuliani, M; Baumann, K; Rodriguez-Carmona, E; Tokkanen, J; Parrilli, E; Wiebe, MG; Kunert, R; Maurer, M; Gasser, B; Sauer, M; Branduardi, P; Pakula, T; Saloheimo, M; Penttila, M; Ferrer, P; Tutino, ML; Villaverde, A; Porro, D; Mattanovich, D Influence of Growth Temperature on the Production of Antibody Fab Fragments in Different Microbes: A Host Comparative Analysis.

BIOTECHNOL PROGR. 2011; 27(1): 38-46. WoS PubMed FullText FullText_BOKU

** Hackl, M; Jakobi, T; Blom, J; Doppmeier, D; Brinkrolf, K; Szczepanowski, R; Bernhart, SH; Siederdissen, CH; Bort, JA; Wieser, M; Kunert, R; Jeffs, S; Hofacker, IL; Goesmann, A; Pühler, A; Borth, N; Grillari, J Next-generation sequencing of the Chinese hamster ovary microRNA transcriptome: Identification, annotation and profiling of microRNAs as targets for cellular engineering..

J Biotechnol. 2011; 153(1-2):62-75 WoS PubMed PUBMED Central FullText FullText_BOKU

** Loos, A; Van Droogenbroeck, B; Hillmer, S; Grass, J; Kunert, R; Cao, JY; Robinson, DG; Depicker, A; Steinkellner, H Production of monoclonal antibodies with a controlled N-glycosylation pattern in seeds of Arabidopsis thaliana.

PLANT BIOTECHNOL J. 2011; 9(2): 179-192. WoS PubMed FullText FullText_BOKU

** Loos, A; Van Droogenbroeck, B; Hillmer, S; Grass, J; Pabst, M; Castilho, A; Kunert, R; Liang, M; Arcalis, E; Robinson, DG; Depicker, A; Steinkellner, H Expression of antibody fragments with a controlled N-glycosylation pattern and induction of endoplasmic reticulum-derived vesicles in seeds of Arabidopsis..

Plant Physiol. 2011; 155(4):2036-2048 WoS PubMed PUBMED Central FullText FullText_BOKU

** Maeso, R; Huarte, N; Julien, JP; Kunert, R; Pai, EF; Nieva, JL Interaction of Anti-HIV Type 1 Antibody 2F5 with Phospholipid Bilayers and Its Relevance for the Mechanism of Virus Neutralization.

AIDS RES HUM RETROV. 2011; 27(8): 863-876. WoS FullText FullText_BOKU

* Kunert, R; Mader, A; (2011): Anti-idiotypic antibody Ab2/3H6 mimicking gp41: a potential HIV-1 vaccine?.

BMC Proc. 2011; 5 Suppl 8:P64 PubMed PUBMED Central FullText FullText_BOKU

* Reinhart, D., Weik, R., Kunert, R. (2011): 3D6 and 4B3: Recombinant expression of two anti-gp41 antibodies as dimeric and secretory IgA.

BMC Proceedings, 5, P56-P56; ISSN 1753-6561 FullText

PUBLIZIERTER Beitrag für wissenschaftliche Veranstaltung

Castilho, A., Gattinger, P., Pabst, M., Grass, J., Kunert, R., Strasser, R., Altmann, F., Steinkellner, H (2011): Humanization of the plant N-glycosylation pathway for the production of therapeutically relevant proteins .
[Glyco 21, XXI International Symposium on Glycoconjugates, Vienna, Austria, AUGUST 21-26, 2011]

, Glycoconjugate Journal, 28, 240-240; ISSN 0282-0080

Renate Kunert (2011): Recombinant human IgMs: Purification, characterization and modification.
[The new ParadIgM – IgM from bench to clinic , Frankfurt am Main, 15.-16.11.2011]

In: Dechema Biotechnologie, Workshop: The new ParadIgM – IgM from bench to clinic

Renate Kunert Alexander Mader (2011): Anti-idiotypic antibody Ab2/3H6 mimicking gp41: a potential HIV-1 vaccine?. [Poster]
[22nd ESACT Meeting, Vienna, Austria, 15.05.2011 - 18.05.2011]

, BMC Proceedings, 5; ISSN 1753-6561

2010

Originalbeitrag in Fachzeitschrift

** Apellaniz, B; García-Sáez, AJ; Huarte, N; Kunert, R; Vorauer-Uhl, K; Katinger, H; Schwille, P; Nieva, JL Confocal microscopy of giant vesicles supports the absence of HIV-1 neutralizing 2F5 antibody reactivity to plasma membrane phospholipids..

FEBS Lett. 2010; 584(8):1591-1596 WoS PubMed FullText FullText_BOKU

** Bohm-Hofstatter, H; Tschernutter, M; Kunert, R Comparison of hybridization methods and real-time PCR: their value in animal cell line characterization.

APPL MICROBIOL BIOTECHNOL. 2010; 87(2): 419-425. WoS PubMed FullText FullText_BOKU

** Castilho, A; Strasser, R; Stadlmann, J; Grass, J; Jez, J; Gattinger, P; Kunert, R; Quendler, H; Pabst, M; Leonard, R; Altmann, F; Steinkellner, H In Planta Protein Sialylation through Overexpression of the Respective Mammalian Pathway.

J BIOL CHEM. 2010; 285(21): 15923-15930. WoS PubMed PUBMED Central FullText FullText_BOKU

** Forthal, DN; Gach, JS; Landucci, G; Jez, J; Strasser, R; Kunert, R; Steinkellner, H Fc-Glycosylation Influences Fc gamma Receptor Binding and Cell-Mediated Anti-HIV Activity of Monoclonal Antibody 2G12.

J IMMUNOL. 2010; 185(11): 6876-6882. WoS PubMed FullText FullText_BOKU

** Gach, JS; Furtmüller, PG; Quendler, H; Messner, P; Wagner, R; Katinger, H; Kunert, R Proline is not uniquely capable of providing the pivot point for domain swapping in 2G12, a broadly neutralizing antibody against HIV-1..

J Biol Chem. 2010; 285(2):1122-1127 WoS PubMed PUBMED Central FullText FullText_BOKU

** Joseph, A; Zheng, JH; Chen, K; Dutta, M; Chen, CD; Stiegler, G; Kunert, R; Follenzi, A; Goldstein, H Inhibition of In Vivo HIV Infection in Humanized Mice by Gene Therapy of Human Hematopoietic Stem Cells with a Lentiviral Vector Encoding a Broadly Neutralizing Anti-HIV Antibody.

J VIROL. 2010; 84(13): 6645-6653. WoS PubMed PUBMED Central FullText FullText_BOKU

** Mader, A; Kunert, R; Humanization strategies for an anti-idiotypic antibody mimicking HIV-1 gp41..

Protein Eng Des Sel. 2010; 23(12):947-954 WoS PubMed FullText FullText_BOKU

** Strobach, S; Kunert, R; Stadlmann, J; Messner, P; Sevcsik, E; Lhota, G; Katinger, H; Vorauer-Uhl, K; Topological transformation of liposomes by a membrane-affecting domain of recombinant human erythropoietin..

J Liposome Res. 2010; 20(1):24-30 WoS PubMed PUBMED Central FullText FullText_BOKU

** Vorauer-Uhl, K; Wallner, J; Lhota, G; Katinger, H; Kunert, R IgM characterization directly performed in crude culture supernatants by a new simple electrophoretic method.

J IMMUNOL METHOD. 2010; 359(1-2): 21-27. WoS PubMed FullText FullText_BOKU

PUBLIZIERTER Beitrag für wissenschaftliche Veranstaltung

** Maeso, R; Kunert, R; Nieva, JL Membrane pore formation by the human immunodeficiency virus type-1 neutralizing anti-gp41 antibody 2F5.

CHEM PHYS LIPIDS. 2010; 163: S46-S46. WoS FullText FullText_BOKU

Renate Kunert, Alexander Mader, Hermann Katinger (2010): Humanization variants of an anti-idiotypic antibody. [Poster]
[Human Antibodies and Hybridomas, Porto, April 14-16, 2010]

In: Mark C Glassy, Human antibodies

2009

Originalbeitrag in Fachzeitschrift

** Kunert, R; Steinfellner, W; Altmann, F; Wallner, J; Katinger, H; Vorauer-Uhl, K; CHO-recombinant human growth hormone as a protease sensitive reporter protein..

Appl Microbiol Biotechnol. 2009; 84(4):693-699 WoS PubMed FullText FullText_BOKU

** Pichler, J; Hesse, F; Wieser, M; Kunert, R; Galosy, SS; Mott, JE; Borth, N A study on the temperature dependency and time course of the cold capture antibody secretion assay..

J Biotechnol. 2009; 141(1-2):80-83 WoS PubMed FullText FullText_BOKU

** Reisinger, H; Steinfellner, W; Katinger, H; Kunert, R Serum-free transfection of CHO cells with chemically defined transfection systems and investigation of their potential for transient and stable transfection.

CYTOTECHNOLOGY. 2009; 60(1-3): 115-123. WoS PubMed PUBMED Central FullText FullText_BOKU

** Stadlmann, J; Weber, A; Pabst, M; Anderle, H; Kunert, R; Ehrlich, HJ; Peter Schwarz, H; Altmann, F; A close look at human IgG sialylation and subclass distribution after lectin fractionation..

Proteomics. 2009; 9(17):4143-4153 WoS PubMed FullText FullText_BOKU

** Strasser, R; Castilho, A; Stadlmann, J; Kunert, R; Quendler, H; Gattinger, P; Jez, J; Rademacher, T; Altmann, F; Mach, L; Steinkellner, H Improved virus neutralization by plant-produced anti-HIV antibodies with a homogeneous beta1,4-galactosylated N-glycan profile..

J Biol Chem. 2009; 284(31):20479-20485 WoS PubMed PUBMED Central FullText FullText_BOKU

PUBLIZIERTER Beitrag für wissenschaftliche Veranstaltung

** Binley, J; Wrin, T; Pantophlet, R; Phung, P; Crooks, ET; Lapedes, A; Taylor, N; Cavacini, L; Steigler, G; Kunert, R; Katinger, H; Petropoulos, C; Richman, D; Morris, L; Sutthent, R; Burton, DR Cross-clade neutralization analysis of plasmas from clade B, C and CRF01_AE HIV-infected donors.

RETROVIROLOGY. 2009; 6: WoS

Glössl, J., Strasser, R., Castilho, A., Kunert, R., Altmann, F., Mach, L., Steinkellner, H. (2009): Glyco-engineering in plants: production of monoclonal antibodies containing homogeneously β1,4-galactosylated human-type N-glycans..
[GLYCOBIOLOGY 2009, SAN DIEGO, CA, NOV 12-15, 2009]

, Glycoconj. Journal, 26, 827

2008

Originalbeitrag in Fachzeitschrift

** Bryson, S; Julien, JP; Isenman, DE; Kunert, R; Katinger, H; Pai, EF Crystal structure of the complex between the F(ab)' fragment of the cross-neutralizing anti-HIV-1 antibody 2F5 and the F(ab) fragment of its anti-idiotypic antibody 3H6..

J Mol Biol. 2008; 382(4):910-919 WoS PubMed FullText FullText_BOKU

** Gach, JS; Quendler, H; Ferko, B; Katinger, H; Kunert, R Expression, purification, and in vivo administration of a promising anti-idiotypic HIV-1 vaccine..

Mol Biotechnol. 2008; 39(2):119-125 WoS PubMed FullText FullText_BOKU

** Gach, JS; Quendler, H; Strobach, S; Katinger, H; Kunert, R Structural analysis and in vivo administration of an anti-idiotypic antibody against mAb 2F5..

Mol Immunol. 2008; 45(4):1027-1034 WoS PubMed FullText FullText_BOKU

** Huarte, N; Lorizate, M; Kunert, R; Nieva, JL Lipid modulation of membrane-bound epitope recognition and blocking by HIV-1 neutralizing antibodies..

FEBS Lett. 2008; 582(27):3798-3804 WoS PubMed FullText FullText_BOKU

** Huarte, N; Lorizate, M; Maeso, R; Kunert, R; Arranz, R; Valpuesta, JM; Nieva, JL The broadly neutralizing anti-human immunodeficiency virus type 1 4E10 monoclonal antibody is better adapted to membrane-bound epitope recognition and blocking than 2F5..

J Virol. 2008; 82(18):8986-8996 WoS PubMed PUBMED Central FullText FullText_BOKU

** Jin, C; Altmann, F; Strasser, R; Mach, L; Schähs, M; Kunert, R; Rademacher, T; Glössl, J; Steinkellner, H A plant-derived human monoclonal antibody induces an anti-carbohydrate immune response in rabbits..

Glycobiology. 2008; 18(3):235-241 WoS PubMed FullText FullText_BOKU

** Menendez, A; Calarese, DA; Stanfield, RL; Chow, KC; Scanlan, CN; Kunert, R; Katinger, H; Burton, DR; Wilson, IA; Scott, JK A peptide inhibitor of HIV-1 neutralizing antibody 2G12 is not a structural mimic of the natural carbohydrate epitope on gp120..

FASEB J. 2008; 22(5):1380-1392 WoS PubMed PUBMED Central FullText FullText_BOKU

** Rademacher, T; Sack, M; Arcalis, E; Stadlmann, J; Balzer, S; Altmann, F; Quendler, H; Stiegler, G; Kunert, R; Fischer, R; Stoger, E Recombinant antibody 2G12 produced in maize endosperm efficiently neutralizes HIV-1 and contains predominantly single-GlcNAc N-glycans..

Plant Biotechnol J. 2008; 6(2):189-201 WoS PubMed FullText FullText_BOKU

** Reisinger, H; Steinfellner, W; Stern, B; Katinger, H; Kunert, R The absence of effect of gene copy number and mRNA level on the amount of mAb secretion from mammalian cells..

Appl Microbiol Biotechnol. 2008; 81(4):701-710 WoS PubMed FullText FullText_BOKU

** Stadlmann, J; Pabst, M; Kolarich, D; Kunert, R; Altmann, F; Analysis of immunoglobulin glycosylation by LC-ESI-MS of glycopeptides and oligosaccharides..

Proteomics. 2008; 8(14):2858-2871 WoS PubMed FullText FullText_BOKU

* Renate Kunert, Johannes Gach, Hermann Katinger (2008): Expression of a Fab Fragment in CHO and Pichia pastoris. A Comparative Case Study.

BioProcess International, June SUPPLEMENT, 34-40; ISSN 1542-6319

* Trummer, E; Ernst, W; Hesse, F; Schriebl, K; Lattenmayer, C; Kunert, R; Vorauer-Uhl, K; Katinger, H; Müller, D (2008): Transcriptional profiling of phenotypically different Epo-Fc expressing CHO clones by cross-species microarray analysis..

Biotechnol J. 2008; 3(7):924-937 PubMed FullText FullText_BOKU

PUBLIZIERTER Beitrag für wissenschaftliche Veranstaltung

Renate Kunert, H. Reisinger, W. Steinfellner, B. Stern, H. Katinger (2008): Influence of different genetic parameters and regulatory sequences on recombinant expression of a monoclonal antibody. [Poster]
[Human Antibodies and Hybridomas, New York, USA, Nov 12-14, 2008 ]

, Human Antibodies, 17, 1,2, 2008, 33-33; ISSN 1093-2607

2007

Originalbeitrag in Fachzeitschrift

** Gach, JS; Maurer, M; Hahn, R; Gasser, B; Mattanovich, D; Katinger, H; Kunert, R High level expression of a promising anti-idiotypic antibody fragment vaccine against HIV-1 in Pichia pastoris..

J Biotechnol. 2007; 128(4):735-746 WoS PubMed FullText FullText_BOKU

** Gach, JS; Quendler, H; Weik, R; Katinger, H; Kunert, R Partial humanization and characterization of an anti-idiotypic antibody against monoclonal antibody 2F5, a potential HIV vaccine?.

AIDS Res Hum Retroviruses. 2007; 23(11):1405-1415 WoS PubMed FullText FullText_BOKU

** Hinterkörner, G; Brugger, G; Müller, D; Hesse, F; Kunert, R; Katinger, H; Borth, N Improvement of the energy metabolism of recombinant CHO cells by cell sorting for reduced mitochondrial membrane potential..

J Biotechnol. 2007; 129(4):651-657 WoS PubMed FullText FullText_BOKU

** Lattenmayer, C; Loeschel, M; Schriebl, K; Steinfellner, W; Sterovsky, T; Trummer, E; Vorauer-Uhl, K; Müller, D; Katinger, H; Kunert, R Protein-free transfection of CHO host cells with an IgG-fusion protein: selection and characterization of stable high producers and comparison to conventionally transfected clones..

Biotechnol Bioeng. 2007; 96(6):1118-1126 WoS PubMed FullText FullText_BOKU

** Lattenmayer C, Trummer E, Schriebl K, Vorauer-Uhl K, Müller D, Katinger H, Kunert R Characterization of Recombinant CHO Cell Lines by Investigation of Protein Productivities and Genetic Parameters..

J BIOTECHNOL, 128 (4), 716-725; ISSN 0168-1656 WoS PubMed FullText FullText_BOKU

** Reisinger, H; Sevcsik, E; Vorauer-Uhl, K; Lohner, K; Katinger, H; Kunert, R Serum-free transfection of CHO-cells with tailor-made unilamellar vesicles..

Cytotechnology. 2007; 54(3):157-168 WoS PubMed PUBMED Central FullText FullText_BOKU

** Sack, M; Paetz, A; Kunert, R; Bomble, M; Hesse, F; Stiegler, G; Fischer, R; Katinger, H; Stoeger, E; Rademacher, T Functional analysis of the broadly neutralizing human anti-HIV-1 antibody 2F5 produced in transgenic BY-2 suspension cultures..

FASEB J. 2007; 21(8):1655-1664 WoS PubMed FullText FullText_BOKU

** Schähs, M; Strasser, R; Stadlmann, J; Kunert, R; Rademacher, T; Steinkellner, H Production of a monoclonal antibody in plants with a humanized N-glycosylation pattern..

Plant Biotechnol J. 2007; 5(5):657-663 WoS PubMed FullText FullText_BOKU

** Schriebl, K; Trummer, E; Weik, R; Lattenmayer, C; Müller, D; Kunert, R; Katinger, H; Vorauer-Uhl, K Applicability of different fluorescent dyes for isoform quantification on linear IPG gels..

Electrophoresis. 2007; 28(12):2100-2107 WoS PubMed FullText FullText_BOKU

** Vcelar, B; Stiegler, G; Wolf, HM; Muntean, W; Leschnik, B; Mehandru, S; Markowitz, M; Armbruster, C; Kunert, R; Eibl, MM; Katinger, H; Reassessment of autoreactivity of the broadly neutralizing HIV antibodies 4E10 and 2F5 and retrospective analysis of clinical safety data..

AIDS. 2007; 21(16):2161-2170 WoS PubMed FullText FullText_BOKU

Originalbeitrag in Sammelwerk

Gach, J., Steinfellner, W., Löschel, M., Hahn, R., Quendler, H., Katinger, H., Kunert, R. (2007): Characterization of an anti-idiotypic antibody blocking the capacity of the HIV-1 specific nMAb 2F5.

In: T. Noll, Animal Cell Technologies; Springer

2006

Originalbeitrag in Fachzeitschrift

** Gasser, B; Maurer, M; Gach, J; Kunert, R; Mattanovich, D; Engineering of Pichia pastoris for improved production of antibody fragments..

Biotechnol Bioeng. 2006; 94(2):353-361 WoS PubMed FullText FullText_BOKU

** Kunert, R; Gach, JS; Vorauer-Uhl, K; Engel, E; Katinger, H; Validated method for quantification of genetically modified organisms in samples of maize flour..

J Agric Food Chem. 2006; 54(3):678-681 WoS PubMed FullText FullText_BOKU

** Lattenmayer, C; Loeschel, M; Steinfellner, W; Trummer, E; Mueller, D; Schriebl, K; Vorauer-Uhl, K; Katinger, H; Kunert, R Identification of transgene integration loci of different highly expressing recombinant CHO cell lines by FISH..

Cytotechnology. 2006; 51(3):171-182 WoS PubMed PUBMED Central FullText FullText_BOKU

** Lorizate, M; Cruz, A; Huarte, N; Kunert, R; Pérez-Gil, J; Nieva, JL Recognition and blocking of HIV-1 gp41 pre-transmembrane sequence by monoclonal 4E10 antibody in a Raft-like membrane environment..

J Biol Chem. 2006; 281(51):39598-39606 WoS PubMed FullText FullText_BOKU

** Sánchez-Martínez, S; Lorizate, M; Hermann, K; Kunert, R; Basañez, G; Nieva, JL Specific phospholipid recognition by human immunodeficiency virus type-1 neutralizing anti-gp41 2F5 antibody..

FEBS Lett. 2006; 580(9):2395-2399 WoS PubMed FullText FullText_BOKU

** Sánchez-Martínez, S; Lorizate, M; Katinger, H; Kunert, R; Nieva, JL Membrane association and epitope recognition by HIV-1 neutralizing anti-gp41 2F5 and 4E10 antibodies..

AIDS Res Hum Retroviruses. 2006; 22(10):998-1006 WoS PubMed FullText FullText_BOKU

** Schriebl, K; Trummer, E; Lattenmayer, C; Weik, R; Kunert, R; Müller, D; Katinger, H; Vorauer-Uhl, K Biochemical characterization of rhEpo-Fc fusion protein expressed in CHO cells..

Protein Expr Purif. 2006; 49(2):265-275 WoS PubMed FullText FullText_BOKU

** Schriebl, K; Trummer, E; Weik, R; Müller, D; Kunert, R; Lattenmayer, C; Katinger, H; Vorauer-Uhl, K A novel strategy for quantitative isoform detection directly performed from culture supernatant..

J Pharm Biomed Anal. 2006; 42(3):322-327 WoS PubMed FullText FullText_BOKU

** Trummer, E; Fauland, K; Seidinger, S; Schriebl, K; Lattenmayer, C; Kunert, R; Vorauer-Uhl, K; Weik, R; Borth, N; Katinger, H; Müller, D Process parameter shifting: Part I. Effect of DOT, pH, and temperature on the performance of Epo-Fc expressing CHO cells cultivated in controlled batch bioreactors..

Biotechnol Bioeng. 2006; 94(6):1033-1044 WoS PubMed FullText FullText_BOKU

** Trummer, E; Fauland, K; Seidinger, S; Schriebl, K; Lattenmayer, C; Kunert, R; Vorauer-Uhl, K; Weik, R; Borth, N; Katinger, H; Müller, D Process parameter shifting: Part II. Biphasic cultivation-A tool for enhancing the volumetric productivity of batch processes using Epo-Fc expressing CHO cells..

Biotechnol Bioeng. 2006; 94(6):1045-1052 WoS PubMed FullText FullText_BOKU

PUBLIZIERTER Beitrag für wissenschaftliche Veranstaltung

Borth N., Brugger G., Hinterkörner G., Ernst W., Müller D., Hesse F., Kunert R., Katinger H. (2006): Cell Line Development by Fluorescence Activated Cell Sorting.
[Engineering Foundation Cell Culture Engineering X, Whistler, Canada, April 2006]

In: Engineering Foundation: Engineering Foundation Cell Culture Engineering X, April 2006, Whistler, Canada

Gach, J., Maurer, M., Quendler, H., Gasser, B., Löschel, M., Mattanovich, M., Katinger, H., Kunert, R. (2006): High Level Expression of a Humanised Ab2/3H6 Fab in Pichia Pastoris..
[Recombinant Antibodies, Zürich, Switzerland, 27-29.06.2006]

In: Prof Dario Neri: Recombinant Antibodies, 27-29.06.2006, Zürich, Switzerland

Kunert, R., Gach, J., Preis, S., Löschel M., Weik, R., Ferko, B., Stiegler, G., Gasser, B., Mattanivich, D., Katinger, H. (2006): In vitro and in vivo characterization of an antiidiotypic antibody variants directed against the HIV-neutralizing mAb 2F5.
[Human Antibodies and Hybridomas, Jamaica, 10. - 12.5.2006]

In: Mark C. Glassy: Human Antibodies and Hybridomas, 10. - 12.5.2006, Jamaica; Human Antibodies, 15 (1,2), 30-31; IOS - Press, Amsterdam Washington, DC Tokyo; ISSN ISSN 1093-2607

Strohbach,St., Wagner,A., Kunert,R., Katinger,H., Vorauer-Uhl, K. (2006): Encapsulation efficiency of lipid nano-vesicles for recombinant human Erythropoietin as a model protein.
[ILS 2006 Annual Meeting, London, 9-12- Dezember 2006]

, International Liposome Society, 1, 53-53

Originalbeitrag in Sammelwerk

Kunert, R., Gach, J., Preis, S., Löschel M., Weik, R., Ferko, B., Stiegler, G., Gasser, B., Mattanivich, D., Katinger, H. (2006): In vitro and in vivo characterization of an antiidiotypic antibody variants directed against the HIV-neutralizing mAb 2F5.

In: Mark C. Glassy, Human Antibodies and Hybridomas; IOS - Press, Amsterdam Washington, DC Tokyo

Skriptum

Borth, N., Gasser, B., Kunert, R., Mattanovich, D., Mattanovich, J., Prenner, C., Reinprecht, B., Voglauer, R., Vorauer-Uhl, K. (2006): Skriptum: Allgemeine Mikrobiologie Übungen.

Borth, N., Gasser, B., Kunert, R., Mattanovich, D., Mattanovich, J., Prenner, C., Reinprecht, B., Voglauer, R., Vorauer-Uhl, K. (2006): Arbeitsprotokolle: Einführung in das Mikrobiologische Arbeiten und Allgemeine Mikrobiologie Übungen.

2005

Originalbeitrag in Fachzeitschrift

** Böhm, E; Grillari, J; Voglauer, R; Gross, S; Ernst, W; Ferko, B; Kunert, R; Katinger, H; Borth, N Establishment of a strategy for the rapid generation of a monoclonal antibody against the human protein SNEV (hNMP200) by flow-cytometric cell sorting..

J Immunol Methods. 2005; 307(1-2):13-23 WoS PubMed FullText FullText_BOKU

** Borth, N; Mattanovich, D; Kunert, R; Katinger, H Effect of increased expression of protein disulfide isomerase and heavy chain binding protein on antibody secretion in a recombinant CHO cell line..

Biotechnol Prog. 2005; 21(1):106-111 WoS PubMed FullText FullText_BOKU

** Cardoso, RM; Zwick, MB; Stanfield, RL; Kunert, R; Binley, JM; Katinger, H; Burton, DR; Wilson, IA Broadly neutralizing anti-HIV antibody 4E10 recognizes a helical conformation of a highly conserved fusion-associated motif in gp41..

Immunity. 2005; 22(2):163-173 WoS PubMed FullText FullText_BOKU

** Haynes, BF; Fleming, J; St Clair, EW; Katinger, H; Stiegler, G; Kunert, R; Robinson, J; Scearce, RM; Plonk, K; Staats, HF; Ortel, TL; Liao, HX; Alam, SM Cardiolipin polyspecific autoreactivity in two broadly neutralizing HIV-1 antibodies..

Science. 2005; 308(5730):1906-1908 WoS PubMed FullText FullText_BOKU

** Nakowitsch, S; Quendler, H; Fekete, H; Kunert, R; Katinger, H; Stiegler, G HIV-1 mutants escaping neutralization by the human antibodies 2F5, 2G12, and 4E10: in vitro experiments versus clinical studies..

AIDS. 2005; 19(17):1957-1966 WoS PubMed FullText FullText_BOKU

** Zeng, Y; Fest, S; Kunert, R; Katinger, H; Pistoia, V; Michon, J; Lewis, G; Ladenstein, R; Lode, HN Anti-neuroblastoma effect of ch14.18 antibody produced in CHO cells is mediated by NK-cells in mice..

Mol Immunol. 2005; 42(11):1311-1319 WoS PubMed FullText FullText_BOKU

** Zwick, MB; Jensen, R; Church, S; Wang, M; Stiegler, G; Kunert, R; Katinger, H; Burton, DR Anti-human immunodeficiency virus type 1 (HIV-1) antibodies 2F5 and 4E10 require surprisingly few crucial residues in the membrane-proximal external region of glycoprotein gp41 to neutralize HIV-1..

J Virol. 2005; 79(2):1252-1261 WoS PubMed PUBMED Central FullText FullText_BOKU

PUBLIZIERTER Beitrag für wissenschaftliche Veranstaltung

Borth N., Böhm E., Grillari J., Löscher M., Gross S., Voglauer R., Ferko B., Kunert R., Katinger H. (2005): From gene to monoclonal antibody: efficient screening by cell sorting.
[Animal Cell Technology meets Genomics, Granada, Spain, May 11 - 15, 2003]

In: Francesc Gòdia Casablancas (Ed.): Animal Cell Technology meets Genomics, May 11 - 15, 2003, Granada, Spain; Proceedings of the ESACT Meeting, 501-504, Granada

Christine Lattenmayer, Martina Löschel, Evelyn Trummer, Karola Vorauer-Uhl, Hermann Katinger, Renate Kunert (2005): Protein free transfection of CHO host cells with and IgG-fusion protein – selection and characterisation of stable high producers.
[Festsymposium 60-Jahre-IAM, Wien, 28.09.2005 - 29.09.2005]

In: IAM: Festsymposium 60-Jahre-IAM, 28.-29.09.2005, Wien

Ernst Böhm, Johannes Grillari, Martina Löschel, Stefan Gross, Regina Voglauer, Renate Kunert, Hermann Katinger, Nicole Borth (2005): From Gene to antibody: efficient screening by cell sorting..
[Festsymposium 60-Jahre-IAM, Wien, 28.09.2005 - 29.09.2005]

In: IAM: IAM Festsymposium 60-Jahre-IAM, 28.-29.09.2005, Wien

Ernst Böhm, Max Zeyda, Willibald Steinfellner, Regina Voglauer, Renate Kunert, Hermann Katinger, Nicole Borth (2005): Sorting for high producers: Methods and application.
[Festsymposium 60-Jahre-IAM, Wien, 28.09.2005 - 29.09.2005]

In: IAM: Festsymposium 60-Jahre-IAM, 28.-29.09.2005, Wien

Gasser B., Maurer M., Kunert R., Mattanovich D. (2005): Optimisation of protein secretion in antibody fragment expressing Pichia pastoris.
[60 Jahre IAM, Wien, Sept. 2005]

In: Institut für Angewandte Mikrobiologie: 60 Jahre IAM, Sept. 2005, Wien

Gudrun Brugger, Dethardt Müller, Renate Kunert, Friedemann Hesse, Hermann Katinger, Nicole Borth (2005): Improvement of the glycolytic metabolism in mammalian cells by fluorescence activated cell sorting.
[Festsymposium 60-Jahre-IAM, Wien, 28.09.2005 - 29.09.2005]

In: IAM: IAM Festsymposium 60-Jahre-IAM, 28.-29.09.2005, Wien

Johannes Gach, Boris Ferko, Brigitte Gasser, Diethardt Mattanovich, Hermann Katinger, Renate Kunert (2005): Anti-idiotypic antibodies, an alternatve strategy against HIV-1.
[Festsymposium 60-Jahre-IAM, Wien, 28.09.2005 - 29.09.2005]

In: IAM: Festsymposium 60-Jahre-IAM, 28.-29.09.2005, Wien

Renate Kunert, Willibald Steinfellner, Martina Löschel, Dethardt Müller, Christine Lattenmayer, Sonja Preis, Johannes Gach, Susanne Wolbank, Regina Voglauer, Hermann Katinger (2005): Protein biopharmaceuticals from mammalian cell technology: from gene ti the master cell bank.
[Festsymposium 60-Jahre-IAM, Wien, 28.09.2005 - 29.09.2005]

In: IAM: Festsymposium 60-Jahre-IAM, 28.-29.09.2005, Wien

Trummer, E., Steinfellner, W., Kunert, R., Steindl, F., Hesse, F., Katinger, H., Müller, D. (2005): Characterisation of CHO Subclones Showing Profound Changes in Performance when Propagated in Different Cultivation Systems (Poster).
[Festsymposium 60-Jahre-IAM, Wien, 28.09.2005 - 29.09.2005]

In: IAM: Festsymposium 60-Jahre-IAM, 28.-29.09.2005, Wien

2004

Originalbeitrag in Fachzeitschrift

** Binley, JM; Wrin, T; Korber, B; Zwick, MB; Wang, M; Chappey, C; Stiegler, G; Kunert, R; Zolla-Pazner, S; Katinger, H; Petropoulos, CJ; Burton, DR Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies..

J Virol. 2004; 78(23):13232-13252 WoS PubMed PUBMED Central FullText FullText_BOKU

** Böhm, E; Voglauer, R; Steinfellner, W; Kunert, R; Borth, N; Katinger, H Screening for improved cell performance: selection of subclones with altered production kinetics or improved stability by cell sorting..

Biotechnol Bioeng. 2004; 88(6):699-706 WoS PubMed FullText FullText_BOKU

** de Rosny, E; Vassell, R; Jiang, S; Kunert, R; Weiss, CD Binding of the 2F5 monoclonal antibody to native and fusion-intermediate forms of human immunodeficiency virus type 1 gp41: implications for fusion-inducing conformational changes..

J Virol. 2004; 78(5):2627-2631 WoS PubMed PUBMED Central FullText FullText_BOKU

** Egelhofer, M; Brandenburg, G; Martinius, H; Schult-Dietrich, P; Melikyan, G; Kunert, R; Baum, C; Choi, I; Alexandrov, A; von Laer, D Inhibition of human immunodeficiency virus type 1 entry in cells expressing gp41-derived peptides..

J Virol. 2004; 78(2):568-575 WoS PubMed PUBMED Central FullText FullText_BOKU

** Kunert, R; Wolbank, S; Stiegler, G; Weik, R; Katinger, H; Characterization of molecular features, antigen-binding, and in vitro properties of IgG and IgM variants of 4E10, an anti-HIV type 1 neutralizing monoclonal antibody..

AIDS Res Hum Retroviruses. 2004; 20(7):755-762 WoS PubMed FullText FullText_BOKU

** Roux, KH; Zhu, P; Seavy, M; Katinger, H; Kunert, R; Seamon, V Electron microscopic and immunochemical analysis of the broadly neutralizing HIV-1-specific, anti-carbohydrate antibody, 2G12..

Mol Immunol. 2004; 41(10):1001-1011 WoS PubMed FullText FullText_BOKU

** Zwick, MB; Komori, HK; Stanfield, RL; Church, S; Wang, M; Parren, PW; Kunert, R; Katinger, H; Wilson, IA; Burton, DR The long third complementarity-determining region of the heavy chain is important in the activity of the broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2F5..

J Virol. 2004; 78(6):3155-3161 WoS PubMed PUBMED Central FullText FullText_BOKU

Kunert, R., Wolbank, S., Chang, M., Voglauer, R., Borth, N., Katinger, H. (2004): Control of Key parameters in developing Mammalian production clones.

BioProcess International, 2, 6, 54-59

2003

** Calarese, DA; Scanlan, CN; Zwick, MB; Deechongkit, S; Mimura, Y; Kunert, R; Zhu, P; Wormald, MR; Stanfield, RL; Roux, KH; Kelly, JW; Rudd, PM; Dwek, RA; Katinger, H; Burton, DR; Wilson, IA Antibody domain exchange is an immunological solution to carbohydrate cluster recognition..

Science. 2003; 300(5628):2065-2071 WoS PubMed FullText FullText_BOKU

** Wolbank, S; Kunert, R; Stiegler, G; Katinger, H Characterization of human class-switched polymeric (immunoglobulin M [IgM] and IgA) anti-human immunodeficiency virus type 1 antibodies 2F5 and 2G12..

J Virol. 2003; 77(7):4095-4103 WoS PubMed PUBMED Central FullText FullText_BOKU

Patent

Katinger, H., Kunert, R., Müller, D., Unterluggauer, F. (2003): Process for the production of polypeptides in mammalian cell cultures.

, 2003-06-10; WO03046162

Zeng, S., Bogner, F.-M., Kunert, R., Müller, D., Unterluggauer, F. (2003): Cell culture process.

, 2003-06-05; WO03045995

PUBLIZIERTER Beitrag für wissenschaftliche Veranstaltung

Borth, N., Böhm, E., Grillari, J., Löscher, M., Gross, S., Voglauer, R., Ferko, B., Kunert, R., Katinger, H. (2003): From gene to monoclonal antibody: efficient screening by cell sorting.
[18th ESACT Meeting - Animal Cell Technology Meets Genomics, Granada, Spain, 11.05.2003 - 14.05.2003]

In: ESACT: 18th ESACT meeting, 11-14 May 2003, Granada, Spain

Hinterleitner, P., Unterluggauer, F., Landauer, K., Müller, D., Kunert, R., Blüml, G., Doblhoff-Dier, O., Katinger, H. (2003): Comparison of fluidized bed and fed-batch reactor cultures for production of anti-HIV antibody.
[18th ESACT Meeting - Animal Cell Technology Meets Genomics, Granada, Spain, 11.05.2003 - 14.05.2003]

In: F. Godia, M. Fussenegger: 18th ESACT Meeting - Animal Cell Techology Meets Genomics, 11.-14.05.2003, Granada, Spain, 253-4; Springer, Dordrecht, The Netherlands; ISBN 1-4020-2791-5

Trummer, E., Müller, D., Steinfellner, W., Kunert, R., Steindl, F., Hesse, F., Katinger, H (2003): Characterisation of CHO subclones showing profound changes in performance when propagated in different cultivation systems.
[18th ESACT Meeting - Animal Cell Technology Meets Genomics, Granada, Spain, 11.05.2003 - 14.05.2003]

In: F. Godia, M. Fussenegger: 18th ESACT Meeting - Animal Cell Technology Meets Genomics, 11.-14.05.2003, Granada, Spain, 529-32; Springer, Dordrecht , The Netherlands; ISBN 1-4020-2791-5

Originalbeitrag in Sammelwerk

Lattenmayer,C., Kunert, R., Katinger, H., (2003): Establishment of screening systems for recombinant cell lines: early prediction of the suitability as a production clone.

In: Godia Francese, Fussenegger Martin, Proceedings of the 18th ESACT Meeting Granada, Spain, May 11-14, 2003, 525-527; Springer, Dordrecht, Netherlands; ISBN 1-4020-2791-5

2002

Originalbeitrag in Fachzeitschrift

** Kunert, RE; Weik, R; Ferko, B; Stiegler, G; Katinger, H Anti-idiotypic antibody Ab2/3H6 mimics the epitope of the neutralizing anti-HIV-1 monoclonal antibody 2F5..

AIDS. 2002; 16(4):667-668 WoS PubMed

** Stiegler, G; Armbruster, C; Vcelar, B; Stoiber, H; Kunert, R; Michael, NL; Jagodzinski, LL; Ammann, C; Jäger, W; Jacobson, J; Vetter, N; Katinger, H; Antiviral activity of the neutralizing antibodies 2F5 and 2G12 in asymptomatic HIV-1-infected humans: a phase I evaluation..

AIDS. 2002; 16(15):2019-2025 WoS PubMed

PUBLIZIERTER Beitrag für wissenschaftliche Veranstaltung

Böhm, E., Borth, N., Voglauer, R., Kunert, R., Ferko, B., Wiederkum, S., Stiegler, G., Hahn, R., Katinger, H. (2002): Efficient selection of monoclonal, antigen-specific and high-producing hybridoma cell lines by flow cytometry and cell sorting: in a single cloning step ?.
[ISAC congress XXI, San Diego, USA, May 2002]

In: ISAC: ISAC congress XXI, May 2002, San Diego, USA

Böhm, E., Borth, N., Voglauer, R., Stiegler, G., Hahn, R., Ferko, B., Kunert, R., Katinger, H. (2002): Efficient Selection of monoclonal, antigen-specific and high-producing Hybridoma Cell Lines in a Single Cloning Step by Flow Cytometry and Cell Sorting..
[UEF Cell Culture Engineering Conference, Snowmass Village, CO, April 2002]

In: UEF: UEF Cell Culture Engineering Conference, April 2002, Snowmass Village, CO

Böhm, E., Voglauer, R., Kunert, R., Grillari, J., Gross, S., Ferko, B., Katinger, H., Borth, N. (2002): Antibody secreting cell lines as model systems for affinity matrix secretion assay based cell sorting..
[15th Heidelberg Cytometry Symposium (HCS) Annual Meeting of the German Society of Cytometry (DGfZ), Heidelberg, Germany, October 2002]

In: German Society of Cytometry: 15th Heidelberg Cytometry Symposium (HCS) Annual Meeting of the German Society of Cytometry (DGfZ), October 2002, Heidelberg, Germany

Borth, N., Böhm, E., Voglauer, R., Steinfellner, W., Kunert, R., Katinger, H. (2002): Screening for Additional Cell Properties: Selection of Subclones with Altered Production Kinetics or Improved Stability by Cell Sorting using an Affinity Matrix Secretion Assay.
[UEF Cell Culture Engineering Conference, Snowmass Village, CO, April 2002]

In: UEF: UEF Cell Culture Engineering Conference, April 2002, Snowmass Village, CO

Voglauer, R., Kunert, R., Steinfellner, W., Katinger, H. (2002): Establishment of human cell lines expressing human Erythropoietin..
[Joint annual meeting of the Österreichische Gesellschaft für Biotechnologie, Salzburg, Austria, September 2002]

In: Österreichische Gesellschaft für Biotechnologie: Joint annual meeting of the Österreichische Gesellschaft für Biotechnologie, September 2002, Salzburg, Austria

Originalbeitrag in Sammelwerk

Kunert, R. and H. Katinger (2002): Production of Immunoglobulins and monoclonal Antibodies targeting Infectious Diseases..

In: Jeffrey M. Jacobson, Immunotherapy for Infectious Diseases, 63-99; Humana Press, Totowa, New Jersey; ISBN 0-89603-669-3

Kunert R., Strutzenberger K., Steindl F., Vecera G., Zudjelovic A., Borth N., Katinger H. (2002): Genetic stability and gene copy number effects. Protein mass production in hybridomas and recombinant CHO cells.

In: (Hrsg.) / (Ed.) / (Eds.): Merten O.-W., Recombinant Protein Production with Prokaryotic and Eukaryotic Cells. A Comparative View on Host Physiology, ??; Kluwer Academic Publishers, USA

Habilitationsschrift

Renate Kunert (2002): Die Entwicklung klinischer Biopharmaka mittels nativer oder rekombinanter Eukaryonten – eine Technologieplattform.

, 102; Habilitation an der Universität für Bodenkultur

2001

Originalbeitrag in Fachzeitschrift

** Borth, N; Zeyda, M; Kunert, R; Katinger, H; Efficient selection of high-producing subclones during gene amplification of recombinant Chinese hamster ovary cells by flow cytometry and cell sorting..

Biotechnol Bioeng. 2001; 71(4):266-273 WoS PubMed

** Bryson, S; Cunningham, A; Ho, J; Hynes, RC; Isenman, DE; Barber, BH; Kunert, R; Katinger, H; Klein, M; Pai, EF Cross-neutralizing human monoclonal anti-HIV-1 antibody 2F5: Preparation and crystallographic analysis of the free and epitope-complexed forms of its F-ab ' fragment.

PROTEIN PEPTIDE LETT. 2001; 8(5): 413-418. WoS

** Grillari, J; Fortschegger, K; Grabherr, RM; Hohenwarter, O; Kunert, R; Katinger, H; Analysis of alterations in gene expression after amplification of recombinant genes in CHO cells..

J Biotechnol. 2001; 87(1):59-65 WoS PubMed

** Stiegler, G; Kunert, R; Purtscher, M; Wolbank, S; Voglauer, R; Steindl, F; Katinger, H; A potent cross-clade neutralizing human monoclonal antibody against a novel epitope on gp41 of human immunodeficiency virus type 1..

AIDS Res Hum Retroviruses. 2001; 17(18):1757-1765 WoS PubMed FullText FullText_BOKU

PUBLIZIERTER Beitrag für wissenschaftliche Veranstaltung

Müller, D., G. Simic, W. Steinfellner, R. Keijzer, R. Kunert, E. Benes, M. Gröschl, F. Trampler, O. Doblhoff-Dier and H. Katinger (2001): Continuous Perfusion versus Discontinous Fed-Batch (oral presentation).
[17th ESACT Meeting - Animal Cell Technology: From Target to Market, Tylösand, Sweden, 10.06.2001 - 14.06.2001]

In: Lindner-Olsson E., Chatizissavidou N., Lüllau E.: 17th ESACT Meeting: Animal cell Technology: from target to market. N. Lindner-Olsson, N. Chatzissavidou and E. Lüllau., 10.-14.6.2001, Tylösand, Sweden, 293-300; Kluwer Academic Publishers, Dordrecht/Boston/London; ISBN 1-4020-0264-5

2000

Originalbeitrag in Fachzeitschrift

** Kunert, R; Steinfellner, W; Purtscher, M; Assadian, A; Katinger, H; Stable recombinant expression of the anti HIV-1 monoclonal antibody 2F5 after IgG3/IgG1 subclass switch in CHO cells..

Biotechnol Bioeng. 2000; 67(1):97-103 WoS PubMed

PUBLIZIERTER Beitrag für wissenschaftliche Veranstaltung

Böhm, E., Borth, N., Voglauer, R., Kunert, R., Steinfellner, W., Katinger, H. (2000): Maintenance of a high antibody expression level in CHO cells without selective and amplification pressure by cell sorting.
[ISAC congress XX, Montpellier, France, May 2000]

In: ISAC: ISAC congress XX, May 2000, Montpellier, France

Borth, N., Böhm, E., Voglauer, R., Kunert, R., Steinfellner, W., Katinger, H. (2000): Maintenance of a high antibody expression level in recombinant CHO cells without selective and amplification pressure by cell sorting..
[Recombinant Protein Production with prokaryotic and eukaryotic cells: A comparative view on host physiology, Semmering, AT, October 2000]

In: Recombinant Protein Production with prokaryotic and eukaryotic cells: A comparative view on host physiology: Recombinant Protein Production with prokaryotic and eukaryotic cells: A comparative view on host physiology, October 2000, Semmering, AT

Voglauer, R., Kunert, R., Hohenwarter, O., Böhm, E., Borth, N., Katinger, H. (2000): Analysis of oncogene expression and chromosomal stability of SV40 early region transfected (ISAC congress XX,.
[ISAC congress XX, Montpellier, France, May 2000]

In: ISAC: ISAC congress XX, May 2000, Montpellier, France

1999

Originalbeitrag in Fachzeitschrift

** Borth, N; Strutzenberger, K; Kunert, R; Steinfellner, W; Katinger, H; Analysis of changes during subclone development and ageing of human antibody-producing heterohybridoma cells by northern blot and flow cytometry..

J Biotechnol. 1999; 67(1):57-66 WoS PubMed

** Strutzenberger, K; Borth, N; Kunert, R; Steinfellner, W; Katinger, H Changes during subclone development and ageing of human antibody-producing recombinant CHO cells..

J Biotechnol. 1999; 69(2-3):215-226 WoS PubMed

** Zeyda, M; Borth, N; Kunert, R; Katinger, H Optimization of sorting conditions for the selection of stable, high-producing mammalian cell lines..

Biotechnol Prog. 1999; 15(5):953-957 WoS PubMed FullText FullText_BOKU

PUBLIZIERTER Beitrag für wissenschaftliche Veranstaltung

Kunert, R., S. Wolbank, A. Hüser and H. Katinger (1999): Analysis of genomic DNA and RNA-Transcripts of a heterohybridoma simultanously expressing IgG3 and IgG1 with identical specificity..
[16th ESACT-Meeting – Animal Cell Technology: Products from Cells, Cells as Products, Lugano, Switzerland, 25.04.1999 - 29.04.1999]

In: B. Bernard, B. Griffith, W. Noe and F. Wurm.: 16th ESACT Conference:Animal cell technology: products from cells, cells as products. , 25-29.4.1999, Lugano, 401-3; Kluwer academic puplisher, Dordrecht/Boston/London; ISBN 0-7923-6075-3

Kunert, R., W. Steinfellner, A. Assadian and H. Katinger (1999): Stable recombinant expression and functional identity of the antio HIV-1 monoclonal antibody 2F5 after IgG3/IgG1 subclass switch in CHO-cells.
[16th ESACT-Meeting – Animal Cell Technology: Products from Cells, Cells as Products, Lugano, Switzerland, 25.04.1999 - 29.04.1999]

In: B. Bernard, B. Griffith, W. Noe and F: 16th ESACT Meeting: Animal cell technology: products from cells, cells as products, 25-29.4.1999, Lugano, 1, 397-399; Kluwer academic Publishers, Dordrecht/Boston/London; ISBN 0-7923-6075-3

1998

Originalbeitrag in Fachzeitschrift

** Kunert, R; Rüker, F; Katinger, H Molecular characterization of five neutralizing anti-HIV type 1 antibodies: identification of nonconventional D segments in the human monoclonal antibodies 2G12 and 2F5..

AIDS Res Hum Retroviruses. 1998; 14(13):1115-1128 WoS PubMed

1997

PUBLIZIERTER Beitrag für wissenschaftliche Veranstaltung

** Borth, N; Strutzenberger, K; Kunert, R; Steinfellner, W; Katinger, H Kinetics and stability of human antibody formation in heterohybridoma and rec: Chinese hamster ovary cells.

ABSTR PAP AMER CHEM SOC. 1997; 213: 62-BIOT. WoS

1996

Originalbeitrag in Fachzeitschrift

** Borth, N., Strutzenberger, K., Donalies, U., Kunert, R., Katinger, H. Comparison of the production of a human monoclonal antibody against HIV-1 by heterohybridoma cells and recombinant CHO cells: a Flow Cytometric study..

Cytotechnology, 22, 129-138 WoS PubMed FullText FullText_BOKU

PUBLIZIERTER Beitrag für wissenschaftliche Veranstaltung

Krumbein, W.E., Gorbushina, A.A., Sterflinger, K., Haroska, U., Kunert, U., Drewello, R., Weißmann, R. (1996): Biodeterioration of historical window panels of the former Cistercian Monastery church of Haina (Hessen, Germany)..

Papers of the 10th International Biodeterioration and Biodegradation Symposium, Hamburg, 15.-18. September 1996, Dechema Monographien, 133, 417-421

1994

Originalbeitrag in Fachzeitschrift

** Buchacher, A; Predl, R; Strutzenberger, K; Steinfellner, W; Trkola, A; Purtscher, M; Gruber, G; Tauer, C; Steindl, F; Jungbauer, A Generation of human monoclonal antibodies against HIV-1 proteins; electrofusion and Epstein-Barr virus transformation for peripheral blood lymphocyte immortalization..

AIDS Res Hum Retroviruses. 1994; 10(4):359-369 WoS PubMed

** Purtscher, M., Gruber, G., Trkola, A., Buchacher, A., Predl, P., Berger, R., Barrett, N., Steindl, F., Tauer, C., Jungbauer, A., Katinger, H. Broadly neutralizing human monoclonal antibodies against gp 41 and gp120 of human immunodeficiency virus type 1 (HIV-1)..

AIDS Res. Hum. Retroviruses, 10, 1651-1658 WoS

Dissertation

Renate Predl (geb. Kunert) (1994): Sequenzierung und systematische Charakterisierung von Genen humaner Antikörper gegen HIV-1 sowie Klonierung in CHO-Zellen und Vergleich der Funktionen rekombinanter humaner mAk mit dem nativen Hybridom Protein.

, 92; Dissertation an der Universität für Bodenkultur

1989

Monographie

Steindl, F., Jungbauer, A., Assadian, A., Blüml, G., Gruber, G., Buchacher, A., Purtscher, M., Hohenwarter, O., Tauer, Ch., Polacsek, K., Maiwald, G., Predl, R., Uhl, K., Katinger, H. (1989): GCSS-General Cell Screening System..

Eigenverlag Inst. f. Angewandte Mikrobiologie, Synopsis

Diplomarbeit / Masterarbeit

Renate Predl (geb. Kunert) (1989): Sialo- und Asialoglykokonjugate als Immunogene: Herstellung und Charakterisierung von Antigenpräparationen und immunologische Austestung.

, 78; Diplomarbeit an der Universität für Bodenkultur

© BOKU Wien Impressum